Three years ago, the smart career move was out of Hong Kong equity capital markets, not into it. Deals had dried up, teams had thinned, and the lawyers who stayed spent a lot of time on restructurings and the occasional block trade. Then the market turned, and it turned hard.
If you are a capital markets lawyer in Hong Kong, or thinking about becoming one, 2026 has brought a confusing kind of good news: a genuine boom that does not want everyone. Hong Kong is the busiest listing venue on the planet again, the pipeline is enormous, and firms are hiring. The demand is also narrow, specific, and focused almost entirely on one thing.
We spend our days talking to lawyers weighing exactly this question. Here is how we read the market, including what the headline numbers leave out.
Why Hong Kong is the world's busiest IPO venue again
From dead market to record books: the 2025-26 turn
In the first three quarters of 2026, Hong Kong hosted 116 listings that raised more than HK$388 billion, more than double the same period a year earlier and higher than any nine-month total in the market's history, according to KPMG. The forecast puts full-year proceeds near HK$500 billion.
This did not come from nowhere. By late 2025, Hong Kong had already reclaimed the top spot for IPO fundraising worldwide, the government confirmed, and independent accountants put HKEX back at number one globally. (For anyone who lived through 2022, that sentence still reads strangely.)
What the headline numbers hide
A record is a record. But a listing total is not a hiring plan, and the two move on different clocks.
Three things sit behind the topline. Fundraising is concentrated in a handful of very large deals, so proceeds can set records while the number of mandates that need staffing grows much more slowly. A listing on a Hong Kong screen is not the same product as a US-securities execution, though candidates routinely conflate the two (more on that below). Firms doing this work also describe themselves as under-resourced after the downturn, hiring toward an optimal headcount rather than over-hiring. The demand is real. It is also rationed. That pattern holds across the region, as we have written in the wider Asia lateral hiring picture.
What is actually driving the capital markets boom in Hong Kong
A+H dual listings: the real engine
The growth engine is not a flood of brand-new companies. It is mainland-listed companies adding a Hong Kong line, the A+H dual listing, alongside a wave of specialist-technology issuers. KPMG names both as the primary drivers.
For a lawyer, that shape matters. A+H work puts a mainland issuer, PRC counsel, Hong Kong law and often US securities law in the same room, on a timetable driven by regulators on two sides of the boundary. It is a cross-border pattern visible elsewhere in the region too, including Japan's parallel deal boom.
The specialist-technology window
The second engine is the specialist-technology listing route for new-economy issuers, and the issuers clustered around it. Most of the record pipeline is AI, robotics and energy-storage firms, according to the exchange.
This feeds straight into hiring. A China-connected deal sheet with a new-economy flavour (tech, healthcare, life sciences) is now what moves a candidate from fitting the mould to being an obvious hire. Generalist or structured-products backgrounds tend to be treated as secondary.
Global funds rebalancing back into China risk
On the demand side, international money is coming back. Global funds that spent years underweight China have been rebuilding exposure, and that cornerstone and institutional demand is helping pull deals to market, the exchange has said.
This is a point to treat carefully. Rebalancing is a flow, and flows reverse. A portfolio decision to stop being underinvested in China is not a decade-long structural shift, even when it produces record quarters while it lasts.
Who is hiring capital markets lawyers in Hong Kong (and who isn't)
The mid-level execution gap the downturn created
Here is the single most important thing to understand. Hiring is concentrated at the mid-level and mid-senior end. Firms want execution associates who can run a deal, not juniors they have to train through a boom, and not, in most cases, senior candidates priced above the roles on offer. If you are much past the ten-year mark, you often sit above the range for the associate seats firms are actually filling.
This is a downturn artefact. Teams that stopped hiring juniors in 2022-2023 now have a hole where their mid-level execution lawyers should be, while a record pipeline is landing on the people who remain. That gap is the opportunity.
The broader recovery supports the picture: recruiters expect Hong Kong finance hiring to rise 10 to 15 percent in 2026, with the strongest demand in revenue-generating front-office roles, Reuters reported. Legal hiring follows that cycle with a lag.
Sponsor-side, issuer-side and international-firm roles
Three broad seats, each with a different job.
- International firms building US-securities capability. US IPOs, follow-ons, 144A/Reg S offerings, tender and exchange offers, Exchange Act reporting. This is US-qualified work and a distinct skill set from HKEX listing practice.
- Issuer-side and local-firm roles. Closer to the mainland issuer and the HKEX process itself.
- Sponsor-side roles. Tied to Hong Kong's sponsor regime and its due-diligence obligations.
We consistently see candidates conflate "capital markets in Hong Kong" with "HKEX listings." The international-firm demand right now is specifically for US-securities execution, and that distinction decides which doors open.
What the work actually demands: qualification, language and stamina
PQE, qualification and the bilingual premium
Two credentials matter more than the rest.
Qualification first. For the US-securities seats, firms want US-qualified lawyers who have executed US offerings. A Hong Kong or England-and-Wales qualification does not substitute for a US-securities deal record on those mandates.
Language second. For the China-facing seats, genuine native-level Mandarin is close to a threshold requirement, not a nice-to-have. You are reading PRC documents and sitting in drafting sessions with mainland issuers and PRC counsel, and the work does not happen in English. But (and this is the part candidates get wrong) Mandarin without a deal record does not get you hired.
“Mandarin opens the room. The deal sheet gets you the seat.”
Deal-execution depth over deal-origination polish
The thing firms weigh most heavily is execution depth: whether you have run the drafting, the diligence, the comment letters and the closing mechanics repeatedly, through completion. Origination polish and client-relationship gloss matter later, at partner level. At the associate and counsel level, the question is narrower. Can you carry a live deal from kickoff to closing with minimal supervision?
Reading the risk: cycle or structure?
The reform pipeline and the A-share backlog
The pipeline is deep: more than 600 active applicants, on KPMG's count. The exchange is also reworking its own rules, with a listing-framework competitiveness review out for consultation since March 2026. Both point to momentum that could outlast any single quarter.
But much of what powers this boom runs on policy. A+H channels, specialist-technology routes and the incentives that smooth mainland-to-Hong-Kong listings are regulatory settings, and regulatory settings have expiry dates. We consistently advise lawyers in this market to test whether a given surge reflects a temporary cyclical rebalancing or durable structural demand before treating it as a safe long-term bet.
How a capital markets lawyer gets caught when volume turns
The way careers get hurt here is predictable. A lawyer relocates or laterals at the top of a cycle, into a team that staffed up for peak volume, assuming the flow is permanent. Then the pipeline thins, the newest and most specialised hires are the most exposed, and the skill set that was scarce is suddenly common. ECM is more cyclical than most practices. Building that into the decision is not pessimism. It is reading the market correctly.
Your next move
This market rewards execution depth and genuine bilingual capability. It hires more at the mid-level than at the junior or senior level, and it runs partly on policy windows that can close. Everything below follows from that.
If you're already in ECM elsewhere
- Audit your deal sheet for China relevance and new-economy exposure first, because that is the axis firms weigh hardest. A China-connected tech, healthcare or life-sciences record moves you from plausible to obvious.
- Separate your US-securities execution from your local-listing experience on paper, because the two open different doors and firms are hiring the first.
- Be honest about your Mandarin, because the China-facing roles treat working fluency as near-threshold, and conversational is not the same thing.
If you're pivoting from M&A or finance
A pivot is possible, but the market is not training juniors through this boom, so you need a bridge. The cleanest is a deal record that already touches securities work: public M&A, take-privates, convertible or debt issuance. Lead with the transferable execution, not the aspiration. (A keyword-honest CV matters more than usual when teams are screening fast, which is the subject of our note on Control-F proofing your resume.)
Timing, and how to test a team before you join
The window for mid-level execution lawyers is open now because of the hole the downturn left, not because the boom will last forever. Moving into the gap is sound. Moving on the assumption of permanence is not. If you are moving to Hong Kong as a lawyer for this, price the cycle in.
Before you sign, ask the team three questions, in this order:
- What is the mix of US-securities execution versus HKEX listing work, because it tells you which skill you will actually build.
- How did this team staff through 2022-2023, because a team that kept its juniors has a different gap than one cut to the bone.
- What does the pipeline look like past the next two quarters, because a record quarter says nothing about the mandate that pays your salary in eighteen months.
The boom is real, and if you have the deal sheet and the language, your bargaining position is real too. The lawyers who do well here treat a record quarter as an opening, not a guarantee, and they join a team for the work it will still be doing when the headline numbers come back to earth. If you want to see which of those seats are live, the open roles are a reasonable place to start.
FAQ
Is now a good time to move into Hong Kong capital markets?
Yes, if you have mid-level execution experience and the deal sheet to prove it. The hiring gap the downturn created is open now and favours lawyers who can run deals with little supervision. It is a weaker time for juniors hoping to be trained through the boom, and for very senior candidates priced above the roles on offer.
Do I need Mandarin to be a capital markets lawyer in Hong Kong?
For the China-facing seats, genuine native-level Mandarin is close to a requirement, because the work runs through mainland issuers and PRC counsel. For some international US-securities roles it matters less than a US-securities deal record. Language alone, without execution depth, does not get you hired.
Will the IPO boom last beyond 2027?
Nobody can promise that. Part of the current volume rests on global funds rebalancing into China and on regulatory settings that support mainland-to-Hong-Kong listings, and both can change. Treat the boom as a strong cycle you can use, and test any team's pipeline beyond the next few quarters before you rely on it.
Is sponsor-side or international-firm ECM the better move?
It depends on the practice you want to build. International-firm roles are weighted toward US-securities execution right now, which is portable and in demand. Sponsor-side and issuer-side roles sit closer to the HKEX process and the mainland issuer. Pick for the skill you want in five years, not just the busiest desk today.
Sources
- KPMG — Chinese Mainland and Hong Kong IPO markets: 2026 Q3 review
- news.gov.hk — HK tops IPO fundraising globally (Financial Leaders' Summit)
- EY — Technology drives A-share momentum; HKEX tops global ranking
- SCMP — Global funds fuel Hong Kong IPO rebound as investors rebalance China portfolios
- HKEX — Listing Framework Competitiveness Review consultation paper (March 2026)
- Reuters — Hiring outlook improves for Hong Kong's financial sector